|
Market Closed -
Nasdaq
16:00:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 1.070 USD | +1.90% |
|
-13.01% | -89.72% |
| Fiscal Period: December | 2018 (USD) | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | -17.66 | -21.1 | -34.53 | -63.21 | -59.44 | |||
Return on Total Capital | -24.79 | -23.71 | -45.88 | -117.33 | -160.77 | |||
Return On Equity % | -130.96 | -40.9 | -73.87 | -191.51 | -327.77 | |||
Return on Common Equity | -713.06 | -40.9 | -73.87 | -191.51 | -327.77 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | 52.86 | 54.27 | 51.45 | 42.93 | 1.25 | |||
SG&A Margin | 89.57 | 126.66 | 128.02 | 141.92 | 354.7 | |||
EBITDA Margin % | -52.8 | -97.71 | -110.82 | -134.22 | -451.94 | |||
EBITA Margin % | -53.21 | -97.92 | -112 | -134.93 | -455.49 | |||
EBIT Margin % | -53.21 | -97.92 | -112.5 | -136.99 | -465.42 | |||
Income From Continuing Operations Margin % | -80.48 | -98.5 | -111.8 | -134.51 | -543.68 | |||
Net Income Margin % | -80.48 | -98.5 | -111.8 | -134.51 | -543.68 | |||
Net Avail. For Common Margin % | -80.48 | -98.5 | -111.8 | -134.51 | -543.68 | |||
Normalized Net Income Margin | -37.88 | -61.56 | -69.87 | -84.07 | -339.8 | |||
Levered Free Cash Flow Margin | -116.89 | -50.76 | -64.48 | -52.63 | -144.25 | |||
Unlevered Free Cash Flow Margin | -112.94 | -50.06 | -63.03 | -51.15 | -143.93 | |||
Asset Turnover | ||||||||
Asset Turnover | 0.53 | 0.34 | 0.49 | 0.74 | 0.2 | |||
Fixed Assets Turnover | 205.51 | 46.93 | 27.12 | 25 | 5.39 | |||
Receivables Turnover (Average Receivables) | 3.22 | 2.4 | 2.89 | 4.24 | 2.58 | |||
Inventory Turnover (Average Inventory) | - | - | - | - | - | |||
Short Term Liquidity | ||||||||
Current Ratio | 13.15 | 4.6 | 1.36 | 0.62 | 1.12 | |||
Quick Ratio | 13.02 | 4.53 | 1.31 | 0.58 | 1.11 | |||
Operating Cash Flow to Current Liabilities | -4.26 | -1.36 | -0.96 | -1.43 | -0.68 | |||
Days Sales Outstanding (Average Receivables) | 113.42 | 152.06 | 126.22 | 86.38 | 141.24 | |||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | |||
Average Days Payable Outstanding | 91.27 | 126.29 | 241.72 | 280.33 | - | |||
Cash Conversion Cycle (Average Days) | - | - | - | - | - | |||
Long Term Solvency | ||||||||
Total Debt/Equity | 11.49 | 0.92 | 2.01 | 9.43 | 8.7 | |||
Total Debt / Total Capital | 10.3 | 0.91 | 1.97 | 8.62 | 8.01 | |||
LT Debt/Equity | 11.49 | 0.13 | 0.3 | 8.12 | 6.86 | |||
Long-Term Debt / Total Capital | 10.3 | 0.13 | 0.29 | 7.42 | 6.31 | |||
Total Liabilities / Total Assets | 16.6 | 17.5 | 38.42 | 64.59 | 67.6 | |||
EBIT / Interest Expense | -2.82 | -42.63 | -48.4 | -57.84 | -905.21 | |||
EBITDA / Interest Expense | -2.8 | -41.79 | -46.94 | -55.95 | -870.37 | |||
(EBITDA - Capex) / Interest Expense | -2.8 | -42.7 | -47.03 | -56.21 | -870.42 | |||
Total Debt / EBITDA | -0.58 | -0.02 | -0.02 | -0.03 | -0.03 | |||
Net Debt / EBITDA | 4.14 | 1.51 | 0.44 | 0.13 | 0.77 | |||
Total Debt / (EBITDA - Capex) | -0.58 | -0.02 | -0.02 | -0.03 | -0.03 | |||
Net Debt / (EBITDA - Capex) | 4.13 | 1.48 | 0.44 | 0.13 | 0.77 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | 36.06 | -6.58 | -4.56 | -6.42 | -79.24 | |||
Gross Profit, 1 Yr. Growth % | 28 | -4.09 | -9.52 | -21.92 | -99.4 | |||
EBITDA, 1 Yr. Growth % | 148.98 | 72.85 | 8.25 | 13.35 | -30.09 | |||
EBITA, 1 Yr. Growth % | 146.23 | 71.91 | 9.17 | 12.74 | -29.91 | |||
EBIT, 1 Yr. Growth % | 146.23 | 71.91 | 9.65 | 13.96 | -29.46 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | 92.64 | 14.33 | 8.33 | 12.6 | -16.09 | |||
Net Income, 1 Yr. Growth % | 92.64 | 14.33 | 8.33 | 12.6 | -16.09 | |||
Normalized Net Income, 1 Yr. Growth % | 45.08 | 51.81 | 8.33 | 12.6 | -16.09 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | - | - | 6.03 | -28.39 | -87.04 | |||
Accounts Receivable, 1 Yr. Growth % | 117.58 | -17.2 | -25.09 | -50.88 | -96.66 | |||
Inventory, 1 Yr. Growth % | - | - | - | - | - | |||
Net Property, Plant and Equip., 1 Yr. Growth % | -56.63 | 1.15K | -21.65 | 31.06 | -30.09 | |||
Total Assets, 1 Yr. Growth % | 475.22 | -31.08 | -35.74 | -40.89 | 1.94 | |||
Tangible Book Value, 1 Yr. Growth % | -190.53 | -41.64 | -84.12 | -180.39 | -140.55 | |||
Common Equity, 1 Yr. Growth % | -209.21 | -31.83 | -52.04 | -66.01 | -6.73 | |||
Cash From Operations, 1 Yr. Growth % | 3.6K | -45.47 | -0.17 | 42.29 | -48.68 | |||
Capital Expenditures, 1 Yr. Growth % | 498.59 | 8.35K | -90.96 | 190.31 | -99.2 | |||
Levered Free Cash Flow, 1 Yr. Growth % | -4.97K | -59.43 | 21.25 | -23.62 | -43.09 | |||
Unlevered Free Cash Flow, 1 Yr. Growth % | -976.95 | -58.59 | 20.15 | -24.05 | -41.58 | |||
Compound Annual Growth Rate Over Two Years | ||||||||
Total Revenues, 2 Yr. CAGR % | 60.95 | 12.74 | -5.58 | -5.49 | -55.92 | |||
Gross Profit, 2 Yr. CAGR % | 64.68 | 10.8 | -6.85 | -15.95 | -93.13 | |||
EBITDA, 2 Yr. CAGR % | 24.02 | 107.45 | 36.79 | 10.77 | -10.98 | |||
EBITA, 2 Yr. CAGR % | 23.58 | 105.74 | 36.99 | 10.94 | -11.11 | |||
EBIT, 2 Yr. CAGR % | 23.58 | 105.74 | 37.3 | 11.78 | -10.35 | |||
Earnings From Cont. Operations, 2 Yr. CAGR % | 37.69 | 48.41 | 11.29 | 10.44 | -2.8 | |||
Net Income, 2 Yr. CAGR % | 37.69 | 48.41 | 11.29 | 10.44 | -2.8 | |||
Normalized Net Income, 2 Yr. CAGR % | 17.56 | 48.41 | 28.24 | 10.44 | -2.8 | |||
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | - | -12.95 | -69.54 | |||
Accounts Receivable, 2 Yr. CAGR % | 91.85 | 34.22 | -21.24 | -39.34 | -87.19 | |||
Net Property, Plant and Equip., 2 Yr. CAGR % | -47.72 | 133.05 | 213.24 | 1.33 | -4.28 | |||
Total Assets, 2 Yr. CAGR % | 191.12 | 99.11 | -33.45 | -38.37 | -22.38 | |||
Tangible Book Value, 2 Yr. CAGR % | 4.02 | -27.31 | -69.56 | -64.27 | -42.9 | |||
Common Equity, 2 Yr. CAGR % | 14.51 | -13.71 | -42.82 | -59.62 | -43.69 | |||
Cash From Operations, 2 Yr. CAGR % | 99.52 | 349.15 | -26.22 | 19.18 | -14.55 | |||
Capital Expenditures, 2 Yr. CAGR % | -69.92 | 2.15K | 176.38 | -48.78 | -84.73 | |||
Levered Free Cash Flow, 2 Yr. CAGR % | 110.31 | 344.61 | -29.87 | -3.76 | -34.07 | |||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 128.12 | 90.56 | -29.46 | -4.47 | -33.39 | |||
Compound Annual Growth Rate Over Three Years | ||||||||
Total Revenues, 3 Yr. CAGR % | 36.33 | 34.26 | 6.65 | -5.86 | -42.97 | |||
Gross Profit, 3 Yr. CAGR % | 42.54 | 37.52 | 3.56 | -12.17 | -83.78 | |||
EBITDA, 3 Yr. CAGR % | 20.93 | 38.53 | 67.02 | 28.48 | -4.99 | |||
EBITA, 3 Yr. CAGR % | 20.86 | 37.95 | 66.56 | 28.38 | -4.81 | |||
EBIT, 3 Yr. CAGR % | 20.86 | 37.95 | 66.81 | 29.03 | -4.12 | |||
Earnings From Cont. Operations, 3 Yr. CAGR % | 18.78 | 29.42 | 33.62 | 11.72 | 0.78 | |||
Net Income, 3 Yr. CAGR % | 18.78 | 29.42 | 33.62 | 11.72 | 0.78 | |||
Normalized Net Income, 3 Yr. CAGR % | 7.23 | 28.01 | 33.62 | 22.8 | 0.78 | |||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | - | -53.86 | |||
Accounts Receivable, 3 Yr. CAGR % | 66.58 | 44.98 | 10.51 | -32.71 | -76.91 | |||
Net Property, Plant and Equip., 3 Yr. CAGR % | -39.64 | 50.71 | 62.05 | 134.28 | -10.46 | |||
Total Assets, 3 Yr. CAGR % | 106.7 | 80.09 | 36.57 | -36.03 | -27.12 | |||
Tangible Book Value, 3 Yr. CAGR % | 10.89 | -14.2 | -56.22 | -57.92 | -62.73 | |||
Common Equity, 3 Yr. CAGR % | 17.37 | -3.67 | -29.05 | -51.92 | -46.62 | |||
Cash From Operations, 3 Yr. CAGR % | 58.45 | 29.48 | 172.07 | -8.16 | -10 | |||
Capital Expenditures, 3 Yr. CAGR % | -64.28 | 97.01 | 257.58 | 180.94 | -87.18 | |||
Levered Free Cash Flow, 3 Yr. CAGR % | - | 21.52 | 188.32 | -27.84 | -19.22 | |||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | 29.16 | 63.41 | -27.7 | -18.91 | |||
Compound Annual Growth Rate Over Five Years | ||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 17.7 | 16.67 | -25.1 | |||
Gross Profit, 5 Yr. CAGR % | - | - | 20.24 | 12.94 | -65.01 | |||
EBITDA, 5 Yr. CAGR % | - | - | 27.04 | 26.68 | 29.85 | |||
EBITA, 5 Yr. CAGR % | - | - | 27.07 | 26.43 | 29.57 | |||
EBIT, 5 Yr. CAGR % | - | - | 27.18 | 26.82 | 30.13 | |||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 15.73 | 21.46 | 17.65 | |||
Net Income, 5 Yr. CAGR % | - | - | 15.73 | 21.46 | 17.65 | |||
Normalized Net Income, 5 Yr. CAGR % | - | - | 15.19 | 20.67 | 17.65 | |||
Accounts Receivable, 5 Yr. CAGR % | - | - | 23.45 | 2.32 | -53.32 | |||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 16.62 | 28.58 | 31.28 | |||
Total Assets, 5 Yr. CAGR % | - | - | 31.36 | 17.28 | 8.95 | |||
Tangible Book Value, 5 Yr. CAGR % | - | - | -33.88 | -39.56 | -51.31 | |||
Common Equity, 5 Yr. CAGR % | - | - | -11.97 | -31.97 | -35.32 | |||
Cash From Operations, 5 Yr. CAGR % | - | - | 16.71 | 25.26 | 71.2 | |||
Capital Expenditures, 5 Yr. CAGR % | - | - | -19.03 | 14.94 | 1.28 | |||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 10.69 | 59.79 | |||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 14.48 | 14.12 |
- Stock Market
- Stocks
- ISPC Stock
- Financials iSpecimen Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















